PERMIDES is one out of five European INNOSUP-1-2015 – Cluster facilitated projects for new value chains projects (funded under EC Call for proposal: H2020-INNOSUP-2015-1).

It is the aim of PERMIDES to strengthen the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment). Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods based.

The voucher funding scheme of PERMIDES is aimed at SMEs from the biopharmaceutical sector developing novel personalized medicine products and solutions (e.g. biotech/medtech companies, diagnostics companies, CROs, biobank companies, bioinformatic companies). Biopharma SMEs can avail benefits from this project for obtaining vouchers up to a maximum of € 60,000. IT SMEs can collaborate with various biopharma SMEs in multiple projects, and are not affected by € 60,000 limit. Potential project team partners can be found via the PERMIDES platform offering the need-vs-expertise-based matchmaking of companies from the biopharmaceutical and IT sector. 

New Deadline (2nd cut-off date for submission of Innovation Voucher Applications) is OCTOBER 10, 2017.

Learn more at: http://permides.eu/open-call/

This project has received funding from the European Union's Horizon 2020 research and Innovation programme under grant Agreement No 691546